Peptide Vaccinations to Treat Patients With Low-Risk Myeloid Cancers

Clinical trial NCT00488592 · COMPLETED

Trial details

NCT number: NCT00488592
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Myelodysplastic Syndrome (MDS)Acute Myeloid Leukemia (AML)Chronic Myeloid Leukemia (CML)

Start date: 2007-06-01
Primary completion: 2010-04-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.